Aligning With Schools To Help Manage Asthma (Project ASTHMA)
Part of paid clinical trials in Buffalo, New York.
- Sponsor
- State University of New York at Buffalo
- Study ID
- NCT03032744
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 4 Years - 14 Years
- Healthy Volunteers
- Accepted
Interventions
- Asthma Assessment & Management — OTHERAsthma Assessment \& Management based on NAEPP-EPR3 guidelines
- Asthma Education — OTHERAsthma education on medications
- Controller medication at school — OTHERStudents will receive the morning dose of their daily preventive asthma medication at school on school days.
Study Details
Project ASTHMA is a school-based health center intervention program that institutes guideline-based chronic asthma care and provides supervised administration with daily preventive asthma medications to improve asthma symptoms and lung function, reduce emergency visits, and decrease missed days of school among children from communities with health disparities.
Key Dates
- Start date
- Jan 17, 2017
- Status verified
- Jan 2026
- Primary completion
- Jul 31, 2019
- Completion
- Jun 30, 2020
Study Design
- Enrollment
- 29 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: InterventionAll participants will undergo an initial asthma assessment per the NAEPP-EPR3 (National Asthma Education and Prevention Program - Expert Panel Report 3) guidelines, as well as asthma education. Participants randomized to the intervention group will be prescribed the appropriate asthma therapy based on their assessment (i.e. providing 'asthma assessment \& management'), and receive the morning dose of their daily asthma controller medication at school on school days.
- Active Comparator: Usual CareAll participants will undergo an initial asthma assessment per the NAEPP-EPR3 (National Asthma Education and Prevention Program - Expert Panel Report 3) guidelines, as well as asthma education. Participants randomized to the usual care group will be provided with the results of their asthma assessment and be instructed to follow up with their primary care provider. They will continue to receive all of their daily asthma controller medication at home.
Primary Outcome Measure
Change in Number of Days Per Week, in the Previous 4 Weeks, of Daytime Asthma Symptoms From Baseline to 7-month Follow-up [ Time Frame: Baseline, 1-month, 3-month, 5-month, 7-month ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| John R. Oishei Children's Hospital | Buffalo | New York | 14203 | - |
Find similar trials in Buffalo, NY
By condition
By specialty
By research site
Related Studies
- Registry of Asthma Characterization and Recruitment 3 (RACR3)Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Aurora, Colorado
- BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled AsthmaRecruiting · Columbia University · Beacon, New York
- A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)PHASE3 · Recruiting · AstraZeneca · Mobile, Alabama
- A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With AsthmaPHASE3 · Recruiting · GlaxoSmithKline · Birmingham, Alabama